India's new intellectual property rights (IPR) policy attempts to address concerns of developed countries regarding India's patent regime, while also protecting public interest, especially that of generic drug producers. However, through this effort of a balancing act, India might have landed up pleasing neither the USTR or U.S. business and disappointing many in India's domestic industry and civil society.
- Central Asia
- East Asia
- South Asia
- South East Asia
- West Asia
- Global Commons
- Book Reviews
- Conference Reports
- GH in the Media
- GH Wiki
- Maps and Infographics
- Partner Publication
- Podcasts and Videos
- Research Papers
- Research Reports
The Indian Space Programme has a mandate to focus on its launch- and earth-oriented capabilities. In the past decade, it has attempted some non-conventional experimental projects under the labels “‘low-cost” and “technology demonstrator”. However the effect of these experimental space projects on India’s techno-economic growth will be realised only if the central government gives the project greater status and funding.
The Trans-Pacific Partnership has dropped strong Intellectual Property Rights regulations on India’s doorstep. The implications of these regulations could affect India’s own policies, as well as her global aspirations towards the potential Regional Comprehensive Economic Partnership.
A tectonic shift is occurring in the science landscape, wherein newly-developed nations are audaciously investing in frontier scientific research at par with developed nations. India is game to join this new wave of advancement, but its research-funding mechanisms are deficient. Can Indian philanthropy endow indigenous R&D?
Ambassador Neelam Deo, Director, Gateway House delivered a lecture at the West Bengal National University of Juridical Sciences, Kolkata on 30 January, 2016.
The controversy surrounding Facebook’s Free Basics in India highlights a key dilemma currently faced by policy makers and private entrepreneurs who wish to foster, not just ‘inclusion’, but business models which foster economic democracy.
The U.S. is urging India to alter its IPR regime, and the potential impact on prices in the pharmaceuticals sector is of concern to African countries that depend on India for low-cost generic medicines. The recent India-Africa Forum Summit in New Delhi sought to address this issue, but it will be a challenge for India to balance competing pressures.
The recent U.S. and China agreement to contain cyber espionage will not only impact their bilateral relationship, it will also create norms in international cyberspace. But implementation remains a challenge, and businesses, including in India, that have faced cyber threats must proactively plug their vulnerabilities
Do the TPP and the proposed India-EU trade deal extend protection of IPR, delaying generic competition for life-saving drugs and keeping their prices high? While these and other possible implications for Indian consumers and pharma companies become clearer over time, India must robustly engage with the debate on trade deals and public interest
Sharad Sharma, co-founder, iSpirt, talks about Prime Minister Modi’s visit to the Silicon Valley on September 27. In an in interview to Gateway House, he outlines the steps that would make Modi’s visit a success for Digital India campaign and other key issues.